COMBACTE-CARE: A New Public-Private Funded Project to Combat Carbapenem Resisitance
Download publication
Related media library items
November 02, 2019
Profile of the SeptiCyte™ LAB Gene Expression Assay to Diagnose Infection in Critically Ill Patients
Abstract. Sepsis is a severe and frequently occurring clinical syndrome, caused by the inflammatory response to infections. Recent studies on the huma...
April 05, 2020
Pharmacodynamic Modelling of β-lactam/β-lactamase Inhibitor Checkerboard Data: Illustration with Aztreonam–Avibactam
Abstract. Objectives. Checkerboard experiments followed by fractional inhibitory concentration (FIC) index determinations are commonly used to assess ...
December 11, 2018
Detection and Prevalence of Carbapenem-resistant Gram-negative Bacteria Among European Laboratories Part of the COMBACTE Network: A COMBACTE LAB-Net Survey
Abstract: Antimicrobial resistance (AMR) represents a global public health threat which jeopardizes the progress that modern medicine has made over th...